ストックスクリーナーアプリを入手
2.34
20.62%
0.40
前日終値:
$1.94
開ける：
$2.065
24時間の取引高:
22.62M
Relative Volume:
2.92
時価総額：
$702.87M
収益：
$188.87M
当期純損益:
$-400.38M
株価収益率:
-1.56
EPS:
-1.5
ネットキャッシュフロー:
$-260.90M
1週間 パフォーマンス:
+15.84%
1か月 パフォーマンス:
+82.81%
6か月 パフォーマンス:
+110.81%
1年 パフォーマンス:
+7.83%
1日の値動き範囲:
$2.05
$2.37
1週間の範囲:
$1.91
$2.37
52週間の値動き範囲:
$0.8511
$2.72
Pacific Biosciences Of California Inc Stock (PACB) Company Profile
名前
Pacific Biosciences Of California Inc
セクター
電話
650-521-8000
住所
1305 O'BRIEN DRIVE, MENLO PARK, CA
PACB を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
PACB
Pacific Biosciences Of California Inc
|
2.34 | 582.72M | 188.87M | -400.38M | -260.90M | -1.50 |
|
ABT
Abbott Laboratories
|
123.62 | 216.79B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
100.72 | 149.02B | 19.35B | 2.78B | 3.49B | 1.8696 |
|
SYK
Stryker Corp
|
356.24 | 141.06B | 23.82B | 2.92B | 4.02B | 7.5574 |
|
MDT
Medtronic Plc
|
90.70 | 116.68B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
82.45 | 49.01B | 5.69B | 1.41B | 577.90M | 1.8485 |
Pacific Biosciences Of California Inc Stock (PACB) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-11-11 | ダウングレード | UBS | Buy → Neutral |
| 2024-06-03 | 再開されました | Jefferies | Buy |
| 2024-04-22 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2024-04-18 | ダウングレード | Goldman | Buy → Neutral |
| 2023-12-14 | 開始されました | Guggenheim | Neutral |
| 2023-12-14 | 開始されました | Stephens | Overweight |
| 2023-12-13 | 開始されました | Wolfe Research | Peer Perform |
| 2023-11-17 | アップグレード | UBS | Neutral → Buy |
| 2023-10-31 | アップグレード | Cantor Fitzgerald | Neutral → Overweight |
| 2023-09-28 | 開始されました | Bernstein | Outperform |
| 2023-07-05 | 再開されました | JP Morgan | Overweight |
| 2023-06-30 | 開始されました | Goldman | Buy |
| 2023-05-10 | 開始されました | Barclays | Equal Weight |
| 2023-03-31 | アップグレード | TD Cowen | Market Perform → Outperform |
| 2023-02-02 | 開始されました | UBS | Neutral |
| 2023-01-20 | ダウングレード | Cantor Fitzgerald | Overweight → Neutral |
| 2023-01-05 | 開始されました | Scotiabank | Sector Outperform |
| 2022-01-21 | 再開されました | Cantor Fitzgerald | Overweight |
| 2022-01-06 | 再開されました | Piper Sandler | Neutral |
| 2021-10-15 | 再開されました | Cowen | Market Perform |
| 2021-09-27 | 開始されました | Canaccord Genuity | Buy |
| 2021-02-11 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2020-11-03 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2020-10-02 | アップグレード | JP Morgan | Neutral → Overweight |
| 2020-09-09 | 開始されました | Morgan Stanley | Equal-Weight |
| 2020-06-02 | 再開されました | Cantor Fitzgerald | Overweight |
| 2020-03-09 | 再開されました | Cantor Fitzgerald | Overweight |
| 2019-10-15 | アップグレード | Piper Jaffray | Neutral → Overweight |
| 2019-04-02 | ダウングレード | Stephens | Overweight → Equal-Weight |
| 2018-10-19 | 開始されました | Cowen | Outperform |
| 2017-11-03 | ダウングレード | First Analysis Sec | Overweight → Equal-Weight |
| 2017-09-28 | ダウングレード | CL King | Buy → Neutral |
| 2016-11-03 | 繰り返されました | Cantor Fitzgerald | Buy |
| 2016-06-27 | 開始されました | CL King | Buy |
| 2016-04-15 | 開始されました | First Analysis Sec | Overweight |
| 2016-02-04 | ダウングレード | Piper Jaffray | Overweight → Neutral |
| 2016-01-04 | 繰り返されました | Cantor Fitzgerald | Buy |
| 2015-10-23 | アップグレード | Piper Jaffray | Neutral → Overweight |
| 2015-08-27 | 開始されました | Cantor Fitzgerald | Buy |
| 2015-02-04 | 繰り返されました | Maxim Group | Buy |
| 2013-09-26 | 繰り返されました | Maxim Group | Buy |
| 2013-01-14 | 繰り返されました | Maxim Group | Buy |
すべてを表示
Pacific Biosciences Of California Inc (PACB) 最新ニュース
Is Pacific Biosciences of California Inc. stock ready for a breakoutEarnings Risk Report & Long-Term Investment Growth Plans - newser.com
Why Pacific Biosciences of California Inc. stock is favored by top institutionsJuly 2025 Selloffs & Safe Entry Point Identification - newser.com
Can Pacific Biosciences of California Inc. stock resist market sell offsTrade Ideas & Verified Technical Signals - newser.com
Will Pacific Biosciences of California Inc. continue its uptrendGold Moves & Low Drawdown Momentum Trade Ideas - newser.com
How to build a custom watchlist for Pacific Biosciences of California Inc.Insider Buying & Safe Capital Allocation Plans - newser.com
Pacific Biosciences of California (NASDAQ:PACB) Shares Gap UpHere's What Happened - MarketBeat
Pacific Biosciences of California (NASDAQ:PACB) Shareholders Are up 16% This Past Week, but Still in the Red Over the Last Five Years - 富途牛牛
Carret Asset Management LLC Buys New Holdings in Pacific Biosciences of California, Inc. $PACB - MarketBeat
Pacific Biosciences of California, Inc. (PACB) latest stock news and headlines - Yahoo! Finance UK
ARK’s PACB Share Buy: Could Institutional Confidence Signal a Turning Point for Pacific Biosciences? - Yahoo Finance
Will Pacific Biosciences of California Inc. stock sustain high P E ratios2025 Technical Patterns & Reliable Price Action Trade Plans - newser.com
Analyzing recovery setups for Pacific Biosciences of California Inc. investorsJuly 2025 Macro Moves & Community Supported Trade Ideas - newser.com
Will Pacific Biosciences of California Inc. stock split attract more investorsMarket Growth Summary & AI Driven Stock Price Forecasts - newser.com
Pacific Biosciences of California emphasizes advanced research initiatives - Traders Union
PacBio (PACB) Shares Skyrocket, What You Need To Know - Yahoo Finance
Smart tools for monitoring Pacific Biosciences of California Inc.’s price actionJuly 2025 Market Mood & AI Based Buy/Sell Signal Reports - newser.com
Can Pacific Biosciences of California Inc. stock deliver strong Q4 earningsMarket Performance Recap & Community Consensus Stock Picks - newser.com
What makes Pacific Biosciences of California Inc. stock attractive to growth fundsJuly 2025 Retail & Smart Allocation Stock Tips - newser.com
Is Pacific Biosciences of California Inc. (P09) stock resilient in recession scenariosPortfolio Value Report & Reliable Price Breakout Alerts - newser.com
How resilient is Pacific Biosciences of California Inc. stock in market downturns2025 Geopolitical Influence & AI Forecast for Swing Trade Picks - newser.com
Ranking Pacific Biosciences of California Inc. among high performing stocks via toolsEntry Point & Stock Market Timing Techniques - newser.com
Does Pacific Biosciences of California Inc. stock trade at a discount to peersTrade Risk Assessment & Reliable Breakout Stock Forecasts - newser.com
Is Pacific Biosciences of California Inc. (P09) stock at risk of policy regulationQuarterly Portfolio Summary & Smart Allocation Stock Tips - newser.com
Genomics Data Analysis Market Size to Surpass USD 28.74 Bn by 2034 - GlobeNewswire Inc.
ARK Investment Acquires 633K Shares of PacBio (PACB) - GuruFocus
Cathie Wood Just Dumped $7.4 Million Worth Of Palantir And AMD Shares — Here's What Ark Is Buying Instead - inkl
Pacific Biosciences of California, Inc. (PACB) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
Publication spotlight:Capturing the full picture of genome editing with custom PureTarget panels - PacBio
Pacific Biosciences of California (PACB) to Release Earnings on Wednesday - MarketBeat
Sumitomo Mitsui Trust Group Inc. Trims Position in Pacific Biosciences of California, Inc. $PACB - MarketBeat
ARK Investment Acquires Over 1 Million Shares of PacBio (PACB) - GuruFocus
Cathie Wood’s ARK ETFs buy DraftKings, Pacific Biosciences stock By Investing.com - Investing.com Nigeria
Cathie Wood’s ARK ETFs buy DraftKings, Pacific Biosciences stock - Investing.com
Pacific Biosciences of California advances antibody development with HiFi Sequencing - Traders Union
Pacific Biosciences of California (NASDAQ:PACB) Stock Price Down 6.5%Time to Sell? - MarketBeat
Pacific Biosciences Of California Inc (PACB) 財務データ
収益
当期純利益
現金流量
EPS
0.34%
14.63%
大文字化:
|
ボリューム (24 時間):